Historic Day for WMers - U.S. FDA Approves Imbruvica (Ibrutinib) for WM
January 29, 2015

In a history-making moment for WM patients, the IWMF is pleased to announce that Imbruvica (ibrutinib) has just received FDA approval specifically for the treatment of WM, thus becoming the first drug therapy to achieve this designation

January 28, 2015

Video presentation by Dr. Mary Lou McMaster to the Northern Virginia IWMF Support Group.

New IWMF Affiliate/Support Group Established in Italy
November 22, 2014

New IWMF Affiliate/Support Group established in Italy

1 2 3 28 29 30